Ovid Therapeutics (OVID) Capital Expenditures (QoQ) (2016 - 2024)
Ovid Therapeutics (OVID) Capital Expenditures (QoQ) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 410.53% |
| Mar 31, 2024 | -72.86% |
| Dec 31, 2023 | 1,066.67% |
| Sep 30, 2023 | -14.29% |
| Jun 30, 2023 | -50.00% |
| Mar 31, 2023 | -88.33% |
| Dec 31, 2022 | 544.83% |
| Sep 30, 2022 | -98.24% |
| Jun 30, 2022 | 3,391.93% |
| Mar 31, 2022 | -81.33% |
| Dec 31, 2021 | 1,437.33% |
| Sep 30, 2021 | -8.51% |
| Dec 31, 2020 | 872.87% |
| Sep 30, 2020 | -35.81% |
| Jun 30, 2020 | -25.99% |
| Mar 31, 2020 | -26.19% |
| Dec 31, 2019 | 5,601.58% |
| Sep 30, 2019 | -160.41% |
| Jun 30, 2019 | -63.67% |
| Mar 31, 2019 | 176.93% |